Skip to content

Bioavailability of Anthocyanins of Blue Potatoes as Compared With Bilberries

Bioavailability of Anthocyanins of Blue Potatoes as Compared With Bilberries

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02005796
Enrollment
14
Registered
2013-12-09
Start date
2013-12-31
Completion date
2015-05-31
Last updated
2015-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postprandial Glycemia

Brief summary

In this study, the postprandial glycemia and insulinemia caused by boiled potato with blue-fleshed or yellow-fleshed tubers, or a gel prepared with bilberries and potato starch, is studied in healthy males. Additionally, the appearance and metabolism of the flavonoids and their metabolites is studied in plasma and urine.

Interventions

OTHERDietary intervention

Sponsors

University of Turku
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18-45 * Male * No regular medication * No participation in a drug trial or blood donation within 2 months * Non-smoker * Signs informed consent * Body mass index 18.5-27 kg/m2 * Fasting plasma cholesterol \< 5.5 mmol/l * Fasting plasma triacylglycerols \< 2.6 mmol/l * Fasting plasma glucose 4-6 mmol/l * blood pressure \<140/80 mmHg * hemoglobin\>130 g/l * Fasting plasma alanine amino transferase (ALAT) \<60 U/l (normal liver function) * Fasting plasma thyroid-stimulating hormone (TSH) 0.4 - 4.5 mU/l (normal thyroid function) * Fasting plasma creatinine \<118 µmol/l (normal kidney function)

Exclusion criteria

* Regular smoking * Alcohol abuse * Regular medication

Design outcomes

Primary

MeasureTime frame
Plasma glucose concentration20min, 40min, 60min, 90min, 120min, 180min, 240min
Plasma insulin concentration20min, 40min, 60min, 90min, 120min, 180min, 240min

Secondary

MeasureTime frame
Concentrations and quality of flavonoid color compounds or their metabolites in plasma and urine (HPLC-measurement)20min, 40min, 60min, 90min, 120min, 180min, 240min
Concentrations and quality of flavonoid color compounds or their metabolites in plasma and urine (NMR-measurement)20min, 40min, 60min, 90min, 120min, 180min, 240min

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026